The Leukemia & Lymphoma Society (LLS) today announced the awarding of 20 grants representing a total investment of $12 million to tackle four areas of high unmet medical need in the blood cancers: malignant stem cells in acute myelogenous leukemia (AML) and myelodysplastic syndromes (MDS); non-cutaneous T-cell malignancies; high-risk myeloma; and long-term and late effects of blood cancer therapies. The grants are in response to request for proposals from researchers in each of these areas. 

Check out our Leukemia Awareness Jewelry @ www.annaslegacy.com